A new fentanyl lozenge will be out soon for cancer patients

January 1999

A new fentanyl lozenge will be out soon for cancer patients. It's called Actiq...and will be promoted by Anesta and Abbott.

Actiq is for "breakthrough" pain in cancer patients who are already on chronic opioids. Breakthrough pain is hard to treat because of its sudden onset and severity.

Actiq works fast...some of the drug is absorbed in the mouth. It starts working within 15 minutes and lasts for several hours.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote